(Circulation. 1996;93:1709-1715.)
© 1996 American Heart Association, Inc.
Articles |
From the Department of Pediatrics and Division of Cardiology (J.T., H.Y.), Department of Internal Medicine, Juntendo University School of Medicine, Tokyo, Japan.
Correspondence to Toshihiro Ino, MD, Department of Pediatrics, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113, Japan.
| Abstract |
|---|
|
|
|---|
Methods and Results Five patients, ranging in age from 2 to 16 years (median, 8 years), underwent conventional PTCA for localized stenosis. The lesion targeted for PTCA was located in the middle right coronary artery of three patients and in the left anterior descending artery in two patients. In four of the five patients, PTCA was angiographically effective, with stenosis rates improving from 84±10% to 33±11% (P<.05). When the previously reported cases of six similar patients were taken into consideration, the only predictor of successful PTCA seemed to be the time elapsed between the onset of Kawasaki disease and performance of this procedure.
Conclusions In cases in which patients show significant localized stenosis as a result of Kawasaki disease, PTCA should be attempted within 6 to 8 years of the onset of the disease. Additionally, intravascular ultrasound imaging was found to be a useful tool for evaluating internal morphology before and after PTCA. In older patients with coronary calcification, other alternatives to PTCA, such as the use of a rotablator or an atherectomy catheter, should be considered.
Key Words: Kawasaki disease aneurysm angioplasty stenosis ultrasonics
| Introduction |
|---|
|
|
|---|
67% after
1 year and 55% after 5 to 9 years. Moreover, these grafts have some
disadvantages: the caliber of autosaphenous vein grafts is too small to
obtain satisfactory long-term patency in small children, and
autosaphenous vein grafts have limited potential for growth. In recent
years, internal mammary artery grafts have been used in bypass surgery
because of their growth potential.2 3 4 However, the
long-term patency of these grafts remains uncertain. On the other hand, percutaneous transluminal coronary angioplasty (PTCA) has rarely been performed as an alternative treatment for severe stenosis of coronary arteries with lesions that result from Kawasaki disease.5 6 7 8 9 This procedure has a limited application in the presence of specific pathological conditions such as marked intimal thickening with calcification.
The present study is a retrospective study that evaluates the effectiveness of PTCA in patients with coronary arterial stenosis as a result of Kawasaki disease.
| Methods |
|---|
|
|
|---|
These latter five patients, ranging in age from 2 to 18 years (with a
median of 8 years), underwent PTCA between January 1990 and February
1995. The ratio of males to females was 4:1. Table 1
shows the clinical details of these cases. During the acute phase,
these patients were diagnosed with Kawasaki disease according to the
clinical criteria established by the Japanese Kawasaki Disease Research
Committee. The case of one patient (patient 5) was previously reported
because of a sib with frequent relapse.10 Treatment in the
acute stage consisted of aspirin plus prednisolone in two patients
(patients 1 and 4), aspirin only in one (patient 2), and aspirin plus a
high dose of
-globulin in one (patient 5). No treatment
information was available regarding the remaining patient (patient 3).
All patients received anticoagulant drugs (aspirin 5 to 10 mg/d with or
without dipyridamole 3 to 5 mg/d PO) from the time the
coronary lesion was first detected until PTCA was performed. No
patient had taken warfarin. None developed cardiac symptoms before PTCA
was performed. The time from the onset of Kawasaki disease until PTCA
treatment ranged from 2 to 16 years (median, 6 years). Calcification of
the coronary artery was detected by fluoroscopy in two patients
(patients 2 and 3). One patient (patient 3) had three ring-shaped
calcifications at the site of the proximal right, left anterior
descending, and left circumflex arteries. Another patient (patient 4)
had a ring-shaped calcification consistent with an
aneurysm of the left anterior descending artery. All patients
received a 2D echocardiogram on hospital admission for PTCA; in four
patients, the test revealed bilateral coronary
aneurysms with no significant hypokinesis of the left
ventricular wall. In one patient (patient 3), global left
ventricular systolic function was slightly reduced
with a posterior wall hypokinesis. None of the patients had an obvious
perfusion defect at rest or after dipyridamole loading
on the 201Tl scintiscan. Informed consent for PTCA was
obtained from the parents of each of the patients.
|
PTCA Methods
In all patients, the catheter was initially inserted through a
right femoral puncture. After we verified right and left
catheterizations by pressure measurement and oximetry,
left ventriculography was performed in the right and left anterior
oblique projections. Right and left coronary
arteriographies were performed in the anteroposterior/lateral and
right/left anterior oblique projections with axial angled
projections. After quantitative coronary arteriography, a
dilating catheter with a 2.25- or 2.5-mm balloon was selected according
to the caliber of the distal coronary artery. The balloon
catheter was introduced by a 7F guiding catheter with a steerable
guidewire and then positioned to straddle the narrowest point. The
balloon was then gradually inflated with diluted contrast medium to a
pressure of 4 to 10 atm. Each inflation lasted
60 to 90 seconds, and
the procedure was repeated until the indentation left by the balloon
disappeared. The right and left coronary arteriograms were
repeated immediately after the procedure. An intravascular ultrasound
study was performed before and after PTCA in only one patient (patient
5) because this technology was unavailable at the time of the other
cases. The PTCA treatment was defined as successful when the rate of
stenosis improved by decreasing to <50% of the
stenosis rate before dilation. A follow-up angiography was
performed 6 to 12 months after the initial angiography.
Assessment of Clinical Predictors for Successful PTCA From
Previous Reports
To identify factors that might impact the effectiveness of PTCA,
clinical and hemodynamic data were obtained from
previously published reports; the data from patients for whom the
procedure was effective were then compared with data from patients for
whom the procedure was ineffective.
Statistical Analysis
The statistical methods used in the present study included
paired and unpaired Student's t tests. A value of
P<.05 was defined as statistically significant.
| Results |
|---|
|
|
|---|
|
|
|
|
Assessment by Review of the Literature
Our literature search uncovered reports of six other
patients.5 6 7 8 9 Clinical details of their cases are
presented in Table 2
. The age of the patients at
the time of PTCA ranged from 3 to 13 years (median, 10 years), and the
time from the onset of disease to the performance of PTCA
ranged from 9 months to 11 years (median, 8 years). The ratio of boys
to girls was 1:1. Angioplasty was performed for native coronary
arterial stenosis in four patients and for
stenosis at the site of the anastomosis between the bypass
graft and the native coronary artery in two patients. Four of
the six patients had successful dilation immediately after the
procedure. One patient had successful dilation immediately after PTCA
but developed restenosis 5 months after the procedure.
|
Fig 5
shows the correlation between the time elapsed
from the onset of the disease to the performance of PTCA and
the effectiveness of PTCA. The time period was significantly longer in
patients with unsuccessful PTCA than in those with successful PTCA
(286±96 versus 103±84 months, P<.05). This was the only
apparent predictor for successful PTCA. Two patients with unsuccessful
PTCA were >12 years old. One of these two patients also had bilateral
ring-shaped coronary calcifications. Factors such as age at
disease onset, lesion site, sex, clinical symptoms, and presence or
absence of a perfusion defect on a 201Tl scintiscan did not
seem to affect the efficacy of PTCA.
|
| Discussion |
|---|
|
|
|---|
In the present study, satisfactory acute results were obtained in patients <8 years of age and with a duration of 6 years between the onset of disease and the performance of PTCA. Previous histopathological examinations by autopsy demonstrated that marked intimal thickening resulting from arteritis was observed at the site of aneurysm and stenosis.11 12 Multiple calcifications were also detected histologically in the arterial wall of the aneurysm even when they could not be identified radiographically. Moreover, intravascular ultrasound imaging revealed intimal-medial thickening of the arterial walls not only at the coronary lesions but also in angiographically normal arteries in the presence of Kawasaki disease.13 All of these findings suggest that the underlying difficulty of balloon angioplasty is attributable to the reduced stiffness or compliance of the arterial wall. However, intimal thickening develops gradually over long periods after inflammation ceases. Previous radiographic studies indicated that calcification in Kawasaki disease usually was detectable at least 6 years after the onset of the disease.14 Therefore, PTCA should be performed on patients <6 to 8 years old. There appears to be no indication for conventional PTCA in children >10 years old with coronary lesions associated with calcification detectable by fluoroscopy. In this setting, alternative treatment, such as the use of a rotablator or an atherectomy, may be attempted. To our knowledge, only two cases treated successfully with a rotablator or directional coronary atherectomy were previously reported.15 16 Factors that would determine the selection of conventional PTCA versus an alternative procedure require further investigation.
In adults, PTCA is indicated by the presence of angina attack, reversible myocardial ischemia, and significant, localized stenosis. Our cases may not have met completely the indication for PTCA in adults; however, the stenosis might have progressed and acute myocardial ischemia might have developed within a few years. This is why PTCA was performed on our patients. Criteria for performance of PTCA in children with Kawasaki disease that are distinct from those for adults have yet to be established.
In the present study, no subjects had clinical symptoms or positive perfusion defect on the 201Tl scintiscan despite angiographic findings of significant stenosis. We could not find a reasonable explanation for this. The severity of these stenoses might be overestimated by selective coronary angiography in some patients. However, there were no significant complications attributable to this procedure. It is possible that conventional PTCA may be indicated in all young children with significant localized stenosis, regardless of whether there are cardiac symptoms or perfusion defects in the 201Tl scintiscan.
The dilation mechanism of PTCA in Kawasaki disease appears to be an intimal-medial flap or tear, which is different from that in atherosclerotic coronary disease. The intravascular ultrasound finding of the dilation mechanism in the present study was consistent with that in congenital arterial stenosis.17 We observed intimal thickening at the site of stenosis by intravascular ultrasound. This finding may be important in the selection of the appropriate device to use to dilate the stenotic lesion. If a marked intimal thickening is found, a rotablator or atherectomy catheter would be considered a more appropriate device than a conventional angioplasty balloon. In the treatment of coronary lesions that result from Kawasaki disease, the use of intravascular ultrasound imaging provides accurate information regarding the internal morphology, which is important for selection of the appropriate interventional catheter. In addition, ultrafast CT scan is also considered to be a sensitive, noninvasive modality for detecting coronary calcification that cannot be found by chest roentgenography.18 Ultrafast CT may become a useful screening modality for the selection of conventional PTCA or other alternatives.
In conclusion, conventional PTCA may be an alternative to aortocoronary bypass surgery in patients with coronary arterial stenosis due to Kawasaki disease. The effectiveness of PTCA depends primarily on the period of time between the disease onset and performance of the procedure. Therefore, conventional PTCA should be performed in patients younger than 8 years old because of the specific histopathological findings in this disease. If the lesion is associated with marked intimal thickening and coronary calcification, an alternative dilation device, such as a rotablator, or atherectomy may be more appropriate. In addition, intravascular ultrasound imaging is a useful modality for evaluating the lumen morphology of the coronary artery before and after coronary intervention.
Received June 27, 1995; revision received October 23, 1995; accepted November 9, 1995.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
J. W. Newburger, M. Takahashi, M. A. Gerber, M. H. Gewitz, L. Y. Tani, J. C. Burns, S. T. Shulman, A. F. Bolger, P. Ferrieri, R. S. Baltimore, et al. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association Pediatrics, December 1, 2004; 114(6): 1708 - 1733. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Newburger, M. Takahashi, M. A. Gerber, M. H. Gewitz, L. Y. Tani, J. C. Burns, S. T. Shulman, A. F. Bolger, P. Ferrieri, R. S. Baltimore, et al. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association Circulation, October 26, 2004; 110(17): 2747 - 2771. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ishii, T. Ueno, H. Ikeda, M. Iemura, T. Sugimura, J. Furui, Y. Sugahara, H. Muta, T. Akagi, Y. Nomura, et al. Sequential Follow-Up Results of Catheter Intervention for Coronary Artery Lesions After Kawasaki Disease: Quantitative Coronary Artery Angiography and Intravascular Ultrasound Imaging Study Circulation, June 25, 2002; 105(25): 3004 - 3010. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tateno, M. Terai, K. Niwa, T. Jibiki, H. Hamada, K. Yasukawa, T. Honda, S. Oana, and Y. Kohno Alleviation of Myocardial Ischemia After Kawasaki Disease by Heparin and Exercise Therapy Circulation, May 29, 2001; 103(21): 2591 - 2597. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Dohmen, M. Dahm, M. Elsner, W. Kasper, and H. Oelert Coronary artery bypass grafting in adult coronary artery disease due to suspected Kawasaki disease in childhood Ann. Thorac. Surg., November 1, 2000; 70(5): 1704 - 1706. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yoshikawa, T. Yagihara, Y. Kameda, S. Taniguchi, E. Tsuda, Y. Kawahira, H. Uemura, and S. Kitamura Result of surgical treatments in patients with coronary-arterial obstructive disease after Kawasaki disease Eur. J. Cardiothorac. Surg., May 1, 2000; 17(5): 515 - 519. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W Newburger and J. C Burns Kawasaki disease Vascular Medicine, August 1, 1999; 4(3): 187 - 202. [Abstract] [PDF] |
||||
![]() |
K. S. Lall, E. Dombrowicz, T. M. Pillay, and J. C.S. Pollock Coronary ostial patch angioplasty in children Ann. Thorac. Surg., May 1, 1999; 67(5): 1478 - 1480. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Burke, R. Virmani, L. W. Perry, L. Li, T. M. King, and J. Smialek Fatal Kawasaki Disease With Coronary Arteritis and No Coronary Aneurysms Pediatrics, January 1, 1998; 101(1): 108 - 108. [Full Text] [PDF] |
||||
![]() |
T. Sugimura, H. Yokoi, N. Sato, T. Akagi, T. Kimura, M. Iemura, M. Nobuyoshi, and H. Kato Interventional Treatment for Children With Severe Coronary Artery Stenosis With Calcification After Long-term Kawasaki Disease Circulation, December 2, 1997; 96(11): 3928 - 3933. [Abstract] [Full Text] |
||||
![]() |
S. Ogawa, R. Fukazawa, T. Ohkubo, J. Zhang, N. Takechi, Y. Kuramochi, Y. Hino, O. Jimbo, Y. Katsube, M. Kamisago, et al. Silent Myocardial Ischemia in Kawasaki Disease : Evaluation of Percutaneous Transluminal Coronary Angioplasty by Dobutamine Stress Testing Circulation, November 18, 1997; 96(10): 3384 - 3389. [Abstract] [Full Text] |
||||
![]() |
P. A. Checchia, E. Pahl, R. E. Shaddy, and S. T. Shulman Cardiac Transplantation for Kawasaki Disease Pediatrics, October 1, 1997; 100(4): 695 - 699. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1996 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |